Recognised in Diagnostics, Wearables & Deep-Tech Platforms
We are pleased to announce that BioAgeDiagnostics has been selected as an official finalist for the 2026 Beauty & Longevity CHOICE Awards in:
DIAGNOSTICS, WEARABLES & DEEP-TECH PLATFORMS
Category: The Empirical Wearables & Diagnostics
The category’s scientific mandate recognises consumer-facing diagnostic tools and therapeutic hardware supported by product-specific clinical literature, tracking software or historical biomarkers to monitor biological ageing over time.
At BioAgeDiagnostics, we are building a precision-health portfolio that brings together genetics, epigenetics, metabolomics, microbiome, clinical biomarkers and longitudinal data to create a more comprehensive view of individual biology.
Within this portfolio, our biological age test SystemAge™ provides the epigenetic ageing layer — analysing 460 biomarkers across 21 organs and physiological systems to reveal how ageing patterns differ across the body.
This is particularly relevant to the award’s focus on empirical measurement and monitoring over time. SystemAge™ moves beyond a single biological age number and provides a baseline that can be revisited longitudinally.
A biomarker moving ≠ ageing trajectory changed.
No single biomarker or measurement can tell the whole story. Understanding whether an intervention is associated with meaningful biological change requires looking across systems and, importantly, measuring repeatedly over time.
That principle extends across our entire portfolio:
Measure → Intervene → Re-measure → Verify.
For BioAgeDiagnostics, being recognised in Diagnostics, Wearables & Deep-Tech Platforms reflects exactly where we believe longevity medicine is heading: integrating multiple layers of biological data and longitudinal measurement to move from isolated biomarkers toward a deeper understanding of individual ageing trajectories.
Precision Healthcare · Longevity Medicine